Macadamia Nuts and Cardiovascular Disease Risk Factors: A Review of Clinical Trials

被引：0
|
作者：
Stewart, Maria [1 ]
机构：
[1] Univ Hawaii Manoa, Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA
来源：
FASEB JOURNAL | 2015年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
923.6
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk factors: Nuts reduce risk of cardiovascular disease
    Lim G.B.
    Nature Reviews Cardiology, 2018, 15 (1) : 4 - 4
  • [2] An Umbrella Review of Nuts Intake and Risk of Cardiovascular Disease
    Schwingshackl, Lukas
    Hoffmann, Georg
    Missbach, Benjamin
    Stelmach-Mardas, Marta
    Boeing, Heiner
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (07) : 1016 - 1027
  • [3] Omega 3 fatty acids in cardiovascular disease risk factors: An updated systematic review of randomised clinical trials
    Rangel-Huerta, Oscar D.
    Gil, Angel
    CLINICAL NUTRITION, 2018, 37 (01) : 72 - 77
  • [4] Nuts and seeds consumption and risk of cardiovascular disease, type 2 diabetes and their risk factors: a systematic review and meta-analysis
    Arnesen, Erik Kristoffer
    Thorisdottir, Birna
    Barebring, Linnea
    Soderlund, Fredrik
    Nwaru, Bright I.
    Spielau, Ulrike
    Dierkes, Jutta
    Ramel, Alfons
    Lamberg-Allardt, Christel
    Akesson, Agneta
    FOOD & NUTRITION RESEARCH, 2023, 67
  • [5] Calcium Intake and Risk of Cardiovascular Disease A Review of Prospective Studies and Randomized Clinical Trials
    Wang, Lu
    Manson, JoAnn E.
    Sesso, Howard D.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (02) : 105 - 116
  • [6] Risk factors: Diabetes and cardiovascular risk: Insights from clinical trials
    Osório J.
    Nature Reviews Cardiology, 2010, 7 (5) : 239 - 239
  • [7] The effect of pomegranate consumption on cardiovascular risk factors in hemodialysis patients: A systematic review of clinical trials
    Baghdadi, Ghazal
    Shidfar, Farzad
    Dehnad, Afsaneh
    PHYTOTHERAPY RESEARCH, 2023, 37 (11) : 4963 - 4975
  • [8] Tracking of cardiovascular risk factors and its implications for clinical trials
    Ulmer, H
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 193S - 193S
  • [9] Learning from large cardiovascular clinical trials: Classical cardiovascular risk factors
    Kempler, P
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 (01) : S43 - S47
  • [10] Clinical review: Growth hormone and cardiovascular risk factors
    Gola, M
    Bonadonna, S
    Doga, M
    Giustina, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03): : 1864 - 1870
12345